Exact Sciences Corp. [EXAS] stock is trading at $48.17, up 2.89%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EXAS shares have gain 2.37% over the last week, with a monthly amount glided 9.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Exact Sciences Corp. [NASDAQ: EXAS] stock has seen the most recent analyst activity on June 27, 2024, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $70. On January 02, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $91 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $90 on December 14, 2023. Wolfe Research initiated its recommendation with a Outperform and recommended $95 as its price target on December 13, 2023. Piper Sandler upgraded its rating to Overweight for this stock on October 10, 2023, but kept the price target unchanged to $90. In a note dated September 28, 2023, Bernstein initiated an Outperform rating and provided a target price of $83 on this stock.
Exact Sciences Corp. [EXAS] stock has fluctuated between $40.62 and $99.56 over the past year. Currently, Wall Street analysts expect the stock to reach $97.2 within the next 12 months. Exact Sciences Corp. [NASDAQ: EXAS] shares were valued at $48.17 at the most recent close of the market. An investor can expect a potential return of 101.79% based on the average EXAS price forecast.
Analyzing the EXAS fundamentals
Exact Sciences Corp. [NASDAQ:EXAS] reported sales of 2.53B for the trailing twelve months, which represents a growth of 5.82%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.08 and Total Capital is -0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.82.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.45 points at the first support level, and at 46.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 48.68, and for the 2nd resistance point, it is at 49.19.
Ratios To Look Out For
For context, Exact Sciences Corp.’s Current Ratio is 1.64. As well, the Quick Ratio is 1.45, while the Cash Ratio is 0.51. Considering the valuation of this stock, the price to sales ratio is 3.51, the price to book ratio is 2.83.
Transactions by insiders
Recent insider trading involved Conroy Kevin T, President and CEO, that happened on May 01 ’24 when 1155.0 shares were sold. Chief Commercial Officer, Cunningham Everett completed a deal on May 01 ’24 to sell 136.0 shares. Meanwhile, Chief Financial Officer Elliott Jeffrey Thomas sold 136.0 shares on May 01 ’24.
